Figure 1.
Cellular and molecular assays. (A) Cell viability as evaluated by cell counting through trypan blue staining. (B) Apoptotic induction, as determined through annexin V-specific antibody and propidium iodide (PI) staining, and followed by flow cytometry analysis. (C) Loss of mitochondria ΔΨm, as evaluated by rhodamine 123 and PI double staining, and followed by flow cytometry analysis. (D) Comparison between microarray (▪) and real-time RT-PCR data (♦). C indicates control; A, ATO; S, imatinib mesylate; A+S, ATO plus imatinib mesylate.

Cellular and molecular assays. (A) Cell viability as evaluated by cell counting through trypan blue staining. (B) Apoptotic induction, as determined through annexin V-specific antibody and propidium iodide (PI) staining, and followed by flow cytometry analysis. (C) Loss of mitochondria ΔΨm, as evaluated by rhodamine 123 and PI double staining, and followed by flow cytometry analysis. (D) Comparison between microarray (▪) and real-time RT-PCR data (♦). C indicates control; A, ATO; S, imatinib mesylate; A+S, ATO plus imatinib mesylate.

Close Modal

or Create an Account

Close Modal
Close Modal